Biomaterial Database

Factors that affect the induction of gamma glutamyltransferase in epileptic patients receiving anti-convulsant drugs. 1987

S A Braide, and T J Davies

Department of Pathology, University of Leicester, UK.

Serum samples from 335 epileptic patients receiving one or more anticonvulsant drugs, phenobarbitone, primidone and phenytoin, have been analysed for biochemical liver profile (BLP) and serum drug concentration. The results show that the induction of serum gamma glutamyltransferase (GGT) is affected by the sex and age of the patient, type of anti-convulsant drug prescribed and duration of treatment. It is less affected by serum drug concentration. It is suggested that these factors must be considered when interpreting results involving serum GGT activity as the index of microsomal enzyme induction.

UI	MeSH Term	Description	Entries
D007223	Infant	A child between 1 and 23 months of age.	Infants
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D010634	Phenobarbital	A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.	Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D010672	Phenytoin	An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs.	Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D011324	Primidone	A barbiturate derivative that acts as a GABA modulator and anti-epileptic agent. It is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite.	Desoxyphenobarbital,Primaclone,Apo-Primidone,Liskantin,Misodine,Mizodin,Mylepsinum,Mysoline,Primidon Holsten,Resimatil,Sertan,Apo Primidone
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002675	Child, Preschool	A child between the ages of 2 and 5.	Children, Preschool,Preschool Child,Preschool Children
D004305	Dose-Response Relationship, Drug	The relationship between the dose of an administered drug and the response of the organism to the drug.	Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359	Drug Therapy, Combination	Therapy with two or more separate preparations given for a combined effect.	Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

S A Braide, and T J Davies

Anti-convulsant, anti-epileptic anti-parkinsonism drugs.

January 1953, American practitioner and digest of treatment,

S A Braide, and T J Davies

[Determination of gamma-glutamyltransferase in patients with chronic anti-epileptic, neuroleptic and anti-parkinsonism therapy].

February 1978, Bollettino della Societa italiana di biologia sperimentale,

S A Braide, and T J Davies

Serum 5'-nucleotidase in patients receiving anti-epileptic drugs.

August 1985, American journal of clinical pathology,

S A Braide, and T J Davies

Isoforms of serum gamma-glutamyltransferase in epileptic patients treated with enzyme-inducing anticonvulsant drugs.

November 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,

S A Braide, and T J Davies

[Elevation of gamma-glutamyltransferase levels in treated epileptic patients].

April 1986, Presse medicale (Paris, France : 1983),

S A Braide, and T J Davies

Factors influencing reactions to anti-convulsant drugs.

January 1993, Adverse drug reactions and toxicological reviews,

S A Braide, and T J Davies

Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs.

January 2015, Archives of physiology and biochemistry,

S A Braide, and T J Davies

Psoriasis and anti-convulsant drugs.

November 1969, The British journal of dermatology,